LPL Financial
CABA icon

LPL Financial’s Cabaletta Bio CABA Stock Holding History

LPL Financial’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Buy
79,075
+9,500
+14% +$31.2K ﹤0.01% 5604
2026
Q1 		$187K Buy
69,575
+26,960
+63% +$74.9K ﹤0.01% 5527
2025
Q4 		$93.3K Buy
+42,615
New +$106K ﹤0.01% 5613
2025
Q2 		– Sell
-10,412
Closed -$14.4K – 5571
2025
Q1 		$14.4K Sell
10,412
-31,974
-75% -$68.1K ﹤0.01% 5289
2024
Q4 		$96.2K Buy
42,386
+5,716
+16% +$20.1K ﹤0.01% 5002
2024
Q3 		$173K Buy
36,670
+7,229
+25% +$41.8K ﹤0.01% 4770
2024
Q2 		$220K Sell
29,441
-5,492
-16% -$67.3K ﹤0.01% 4493
2024
Q1 		$596K Sell
34,933
-2,705
-7% -$58.1K ﹤0.01% 3630
2023
Q4 		$854K Sell
37,638
-223
-0.6% -$3.75K ﹤0.01% 3179
2023
Q3 		$576K Buy
37,861
+6,258
+20% +$85.5K ﹤0.01% 3363
2023
Q2 		$408K Buy
31,603
+6,823
+28% +$74.1K ﹤0.01% 3609
2023
Q1 		$205K Buy
+24,780
New +$232K ﹤0.01% 4024

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

LPL Financial's CABA Position: Q2 2026 in Review

LPL Financial increased its Cabaletta Bio (CABA) stake by 14% in Q2 2026, buying an estimated $31.2K and bringing the position to 79,075 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #5604.

LPL Financial first reported a position in CABA in Q1 2023 and has held it in 12 quarters since. The position peaked at $854K in Q4 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • LPL Financial held 79,075 shares of Cabaletta Bio worth $246K as of Q2 2026.
  • LPL Financial bought 9,500 Cabaletta Bio shares in Q2 2026, an estimated $31.2K.
  • Cabaletta Bio made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5604 holding.
  • LPL Financial first reported a position in Cabaletta Bio in Q1 2023 and has held it in 12 quarters since.
  • LPL Financial's Cabaletta Bio position peaked at $854K in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.